News

The Phase II multi-center, double-blind, placebo-controlled trial will be conducted in the US and will evaluate the analgesic efficacy and safety of intravenous CR845 during the post-operative period

Under the terms of the agreement, Champions will use its Biomerk Tumorgraft preclinical platform to evaluate a combination therapy indication for Salirasib, a Ras antagonist. This agreement modifies

The proceeds from the financing will be used to provide the financial flexibility to advance partnering and M&A discussions for Urigen’s URG101 program for painful bladder syndrome and

Under the terms of the agreement, AuricX gained rights from SRI to oral formulations of the antibiotic vancomycin. SRI received upfront payments and will be eligible for success-based

Based on positive initial treatments in a rat model of Parkinson’s disease, conducted by David Yurek at University of Kentucky, a second Phase of studies will now work

In addition, the company announced that the FDA has granted expedited review status to the Alair system. Bronchial thermoplasty with the Alair system is an investigational procedure that

Under the terms of the agreement, Forma will leverage its transformative biology and chemistry platform to develop inhibitors for an undisclosed protein-protein interaction target in the field of

The two companies have formed a global platform for the introduction of the Sohm brand of generic medicines into the African, Latin American, and Southeast Asian markets. Generic

The clinical trial is an international, multi-center, placebo-controlled study that will examine the effectiveness of SLC022 in controlling pain associated with post-herpetic neuralgia (PHN). Solace anticipates having results